KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Factset Research Systems (FDS) Cash & Equivalents (2016 - 2025)

Factset Research Systems (FDS) has disclosed Cash & Equivalents for 17 consecutive years, with $337.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 20.17% year-over-year to $337.7 million, compared with a TTM value of $337.7 million through Aug 2025, down 20.17%, and an annual FY2025 reading of $337.7 million, down 20.17% over the prior year.
  • Cash & Equivalents was $337.7 million for Q3 2025 at Factset Research Systems, up from $278.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $773.0 million in Q1 2022 and bottomed at $278.5 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $494.7 million, with a median of $453.1 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents soared 75.46% in 2021, then decreased 29.79% in 2024.
  • Year by year, Cash & Equivalents stood at $673.9 million in 2021, then dropped by 25.32% to $503.3 million in 2022, then dropped by 18.16% to $411.9 million in 2023, then fell by 29.79% to $289.2 million in 2024, then increased by 16.77% to $337.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for FDS at $337.7 million in Q3 2025, $278.5 million in Q1 2025, and $289.2 million in Q4 2024.